Completed NA INTERVENTIONAL 1-arm NCT01053559

Assessment of Small Bowel Healing in Crohn's Disease Patients Treated With Cimzia Using Wireless Capsule Endoscopy

Open Label Investigator Initiated, Single Site Study of Mucosal Healing in Patients With Small Bowel Crohn's Disease Treated With Certolizumab Pegol (Cimzia) Assessed by Wireless Capsule Endoscopy

Sponsor: Shafran Gastroenterology Center

Conditions Crohn's Disease

Interventions certolizumab pegol

Updated 5 times since 2017 Last updated: Apr 23, 2014 Started: Jan 31, 2010 Primary completion: Sep 30, 2013 Completion: Sep 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Crohn's Disease, this trial is completed. The trial is conducted by Shafran Gastroenterology Center and has accumulated 5 data snapshots since 2010. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shafran Gastroenterology Center
UCB Pharma

Data source: Shafran Gastroenterology Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Winter Park, United States